Among the targets identified, deletion of the protein tyrosine phosphatase PTPN2 in tumor cells showed particular promise by enhancing the efficacy of immunotherapy through its effect on interferon-γ-mediated antigen presentation and growth suppression. Here, PTPN2 is linked to neoplasm.